Clinical Trials

Showing trials with last updates posted in 2026.

NCT07468071 | RECRUITING | PHASE1/PHASE2
40 participants

Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-01
Start Date:
2026-06-08
Completion:
2029-06-11
Conditions
  • Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung Cancer
  • Advanced Solid Tumors Harboring the KRAS G12C Mutation
Interventions
  • DRUG
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page